4//SEC Filing
Meyers Michael L. 4
Accession 0001562180-21-002976
CIK 0001395937other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:15 PM ET
Size
4.7 KB
Accession
0001562180-21-002976
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2021-04-26$15.46/sh+500$7,730→ 15,666 total
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001664204
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:15 PM ET
- Size
- 4.7 KB